We are live on ! Find out more

PSTV

Plus Therapeutics

PSTV

Delisted

PSTV was delisted on the 31st of July, 2026.

5 hedge funds and large institutions have $1.12M invested in Plus Therapeutics in 2017 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New

Increased

Maintained

Reduced

Closed

17% more capital invested

Capital invested by funds: $952K → $1.12M (+$164K)

0% more funds holding

Funds holding: 5 → 5 (0)

0% more ownership

Funds ownership: 0% → 0% (+0%)

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

Holders

Holders Change

–

Holders Change %

% of All Funds

0.11%

Holding in Top 10

–

Holding in Top 10 Change

–

Holding in Top 10 Change %

–

% of All Funds

–

New

Increased

Reduced

Closed

Calls

–

Puts

–

Net Calls

–

Net Calls Change

–

Top Buyers

Rank	Fund	Capital Flow
1	PCM Perkins Capital Management Wayzata, Minnesota	+$420K
2	Jane Street New York	+$70.1K

Top Sellers

Rank	Fund	Capital Flow
1	Vanguard Group Malvern, Pennsylvania	-$70.1K
2	Renaissance Technologies New York	-$43K
3	Bank of New York Mellon New York	-$11K
4	VF Virtu Financial New York	-$10K
5	UB UMB Bank Kansas City, Missouri	-$7K

#	Name	Holding	Trade Value	Shares Change	Change in Stake
1	PCM 1 Perkins Capital Management Wayzata, Minnesota	$644K	+$420K	+6	+120%
2	2 Vanguard Group Malvern, Pennsylvania	$166K	-$70.1K	-1	-25%
3	3 BlackRock New York	$97K	–	–	–
4	4 Jane Street New York	$52K	+$70.1K	+1	New
5	5 Geode Capital Management Boston, Massachusetts	$49K	–	–	–
6	6 Susquehanna International Group Bala Cynwyd, Pennsylvania	$24K	–	–	–
7	7 Creative Planning Overland Park, Kansas	$23K	–	–	–
8	8 Northern Trust Chicago, Illinois	$17K	–	–	–
9	9 Macquarie Group Sydney, NSW 2000, Australia	$10K	–	–	–
10	10 Citadel Advisors Miami, Florida	$6K	–	–	–
11	IP 11 Intellectus Partners San Francisco, California	$6K	–	–	–
12	12 HighTower Advisors Chicago, Illinois	$5K	–	–	–
13	13 California Public Employees Retirement System Sacramento, California	$4K	–	–	–
14	FPF 14 FNY Partners Fund New York	$4K	–	–	–
15	MCM 15 Marathon Capital Management Hunt Valley, Maryland	$3K	–	–	–
16	16 UBS Group Zurich, Switzerland	$2K	–	–	–
17	LTFS 17 Ladenburg Thalmann Financial Services Miami, Florida	$1K	–	–	–
18	18 Morgan Stanley New York	$1K	–	–	–
19	PMFA 19 Plante Moran Financial Advisors Southfield, Michigan	$1K	–	–	–
20	20 Royal Bank of Canada Toronto, Ontario, Canada	$1K	–	–	–
21	FDCDDQ 21 Federation des caisses Desjardins du Quebec Levis, Quebec, Canada	$40	–	–	–
22	22 Renaissance Technologies New York	–	-$43K	-1	Closed
23	23 Bank of New York Mellon New York	–	-$11K	–	–
24	24 Simplex Trading Chicago, Illinois	–	-$2K	–	–
25	TSS 25 Two Sigma Securities New York	–	-$6K	–	–

PSTV Hedge Fund Activity: Q4 2017 in Review

5 of the 4,410 institutional investors tracked by Wall St. Rank reported a position in Plus Therapeutics (PSTV) for Q4 2017, worth a combined $1.12M — up 17% from $952K a quarter earlier.

Fund positioning in PSTV was balanced in Q4 2017: 1 fund opened new positions, 1 closed out, 1 added to existing stakes and 1 trimmed.

The largest buyer was Perkins Capital Management, adding an estimated $420K. The largest seller was Vanguard Group, cutting an estimated $70.1K.

5 institutional investors held Plus Therapeutics (PSTV) as of Q4 2017, unchanged from Q3 2017.
Funds reported $1.12M of Plus Therapeutics stock for Q4 2017, up 17% quarter-over-quarter.
1 fund opened new Plus Therapeutics positions in Q4 2017 and 1 closed out, a net change of 0 holders.
The largest Plus Therapeutics buyer in Q4 2017 was Perkins Capital Management, an estimated $420K added.
The largest Plus Therapeutics seller in Q4 2017 was Vanguard Group, an estimated $70.1K sold.

Based on aggregated 13F filings for Q4 2017.

Plus Therapeutics PSTV